Company Filing History:

13 out of 12,160

Bayer Aktiengesellschaft

patents

1 out of 4,945

Hoffmann-la Roche Inc.

where one patent can have more than one assignee

Years Active: 1984-1989

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 4859665 - Antihypertensive combination products containing a dihydropyridine and a (1989-08-22),

2. 4709031 - Imidazothiadiazolealkylene carboxylic acids (1987-11-24),

3. 4703125 - Amidazothiodiazone carbonyl compounds useful to prepare novel (1987-10-27),

4. 4703038 - Combination of dihydropyridines with angiotensin converting (1987-10-27),

5. 4659737 - Substituted aminomethyl benzopyrans having anti-hypertensive activities (1987-04-21),

6. 4657905 - Novel hypotensive imidazothiadiazolealkanecarboxamides (1987-04-14),

7. 4647579 - Circulation active novel substituted 4-hydroxy-benzopyrans (1987-03-03),

8. 4621082 - Pyridopyrimidines, pharmaceutical compositions and use (1986-11-04),

9. 4588723 - Aminoalkyl-imidazothiadiazole-alkenecarboxylic acid amides, (1986-05-13),

10. 4585873 - Novel hypotensive imidazothiadiazolealkenecarboxamides (1986-04-29),

11. 4585772 - Agents for combating circulatory illnesses and their use (1986-04-29),

12. 4582840 - 1,4-dihydro-2,6-dimethyl-4-nitrophenyl-3,5-pyridinedicarboxylic acid (1986-04-15),

13. 4567188 - Hypotensive 2-nitro-1,1-ethenediamines (1986-01-28),

14. 4444770 - New imidazoazole-alkenoic acid amide compounds, intermediate products (1984-04-24),

Title: **Bernward Garthoff: A Pioneer in Antihypertensive Innovations**

Introduction

Bernward Garthoff, a notable inventor based in Hilden, Germany, has made significant contributions to the field of pharmaceuticals, particularly in antihypertensive medication. With a remarkable portfolio of 14 patents, Garthoff has focused on innovative compositions and combinations that effectively treat hypertension.

Latest Patents

Garthoff's latest patents showcase his expertise in developing unique antihypertensive combination products. These include compositions that contain a dihydropyridine, which are crucial in the treatment of hypertension. His inventions highlight specific formulas characterized by the inclusion of various substituents such as nitro, chlorine, and trifluoromethyl. Moreover, he has also explored alkenecarboxylic acids that incorporate complex structures and substituents, enhancing the efficacy of treatments.

Career Highlights

Throughout his career, Garthoff has worked with prestigious companies such as Bayer Aktiengesellschaft and Hoffmann-La Roche Inc. His contributions to these organizations have paved the way for advancements in hypertension treatment, showcasing his commitment to innovation in the pharmaceutical industry.

Collaborations

Garthoff's work has not been done in isolation, as he has collaborated with notable professionals including Horst Meyer and Stanislav Kazda. These partnerships have been pivotal in pushing the boundaries of research and development, allowing for the exploration of new therapeutic strategies.

Conclusion

In summary, Bernward Garthoff stands out as a prominent inventor whose work has greatly impacted the field of antihypertensive medications. With his extensive patent portfolio and collaborations with industry leaders, Garthoff continues to be a driving force in pharmaceutical innovation, aiming to improve the quality of life for patients suffering from hypertension.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com